Latest ArticlesCommercially available prefabricated tryptic soy agar(TSA) plates are the primary format for culture media used in environmental monitoring. Their quality significantly impacts the accuracy of environmental monitoring.This study evaluated the pH value, gel strength, and growth promotion capability of TSA plates from four different manufacturers in accordance with the Chinese Pharmacopoeia 2020 Edition and relevant standards. Additionally, in alignment with the latest requirements of EU GMP, the effects of environmental exposure and irradiation treatment on the media were investigated. Results showed that the pH value, gel strength, and growth promotion capability of the four TSA plates generally met the standard requirements. Under unexposed or 0.5 h exposure conditions, some plates exhibited pH values exceeding the standard limit. After 4 h of exposure, the moisture loss rates for the plates from four manufacturers were 17.99%, 16.80%, 17.73%, and 18.44%, respectively. Three brands showed recovery rates below 0.5 for Escherichia coli, Pseudomonas aeruginosa, Salmonella, and environmental isolates of Pseudomonas sediminis. While nitrogen content showed no significant changes in pre- and post-irradiation. And increasing irradiation doses led to a dose-dependent decline in pH value, gel strength, and growth promotion capability. These results demonstrated that the irradiation sterilization process significantly compromised the quality of prefabricated TSA plates. In conclusion, users should conduct comprehensive quality assessments of prefabricated TSA in consideration of specific challenges in practical applications(such as exposure handling).
As an emerging precision particle manufacturing technology, microfluidic technology harnesses the unique microfluidic phenomena in microscale environments to achieve continuous and reproducible production of micro/nanoparticles. This review systematically summarizes the structural design principles and operational characteristics of common microfluidic channels, elaborates on recent advances in particle-based drug delivery systems, and highlights its advantages in controlling particle size, manipulating structures, and enhancing process efficiency. Furthermore, this review explores industrialization strategies, technical challenges, and future development directions of microfluidic technology,aiming to serve as a reference for the efficient preparation of micro/nanoparticle-based drug delivery systems.
In biological preparations, parameters such as particle size, shape, and aggregation state can reflect drug stability and serve as critical indicators for safety assessment and immunogenicity prediction. There are various methods for determining particle size and size distribution, among which light scattering method stands out as a rapid, non-invasive, and highly sensitive technique with broad application potential. Its advantages include no requirement for sample dilution, simultaneous measurement of multiple parameters(e.g., size, morphology, and aggregation state of proteins). This technology can make significant contributions to protein solution analysis, drug quality control, optimization of production processes, and drug development. This review summarizes particle size measurement methods, current applications of mainstream light scattering instruments, and how these instruments achieve measurement requirements of biomedical materials and preparations, offering calibration strategies for practical measurements to enhance measurement accuracy for biomedical materials and preparations.
In the research, biphenyl(2) was used as starting material to synthesize 4,4'-bis(2-bromoacetyl)-1,1'-biphenyl(3) with high yield. Then, 4,4'-bis[N-tert-butoxycarbonyl-(2S)-pyrrolidine-2-carbonyloxymethylformyl]-1,1'-biphenyl(5) was synthesized via esterification between 3 and N-tert-butoxycarbonyl-L-proline(4). 4,4'-Bis[2-[N-tert-butoxycarbonyl-(2S)-pyrrolidine-2-yl]-1H-imidazol-5-yl]-1,1'-biphenyl(6) was prepared by ammonolysis and cyclization of 5. Compound 6 was deprotected by hydrochloric acid to give 4,4'-bis[2-[(2S)-pyrrolidine-2-yl]-1H-imidazol-5-yl]-1,1'-biphenyl tetrahydrochloride(7), which was followed by condensation with N-(methoxycarbonyl)-L-valine(8) to give the N,N'-[(1,1'-biphenyl)-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid C,C'-dimethyl ester(9), and 9 went through salt formation with HCl to provide daclatasvir dihydrochloride(1). The total mole yield was 38.5% and purity was 99.75%. The improved process has low cost and mild reaction condition, which is very suitable for industrial production.
A synthetic process of mivacurium chloride(1) was optimized. 3,4,5-Trimethoxyphenylacetic acid(7) and 3,4-dimethoxyphenylethylamine were used as starting materials to obtain the key intermediate (R)-5'-methoxylabdanin[(R)-2] dibenzoyl tartrate through dehydration condensation, intramolecular cyclization, imine reduction,reductive amination, and chiral resolution. Compound (R)-2 dibenzoyl tartrate reacted with 1,3-propylene glycol cyclic sulfate under alkaline conditions via nucleophilic substitution and hydrolysis to obtain its quaternary ammonium alcohol(3).Finally, compound 3 was condensed with trans-4-octene-1,8-dicarboxylic acid to obtain 1. In the post-treatment of the intramolecular cyclization step, omission of alkaline solution for quenching phosphorus oxychloride effectively prevented the formation of oxidative impurities. The synthesis of (R)-2 dibenzoyl tartrate was improved by reducing two resolutions to a single step, increasing the resolution yield from 33% to 42%. Replacing 3-chloropropanol with 1,3-propylene glycol cyclic sulfate during the synthesis of compound 3 eliminated polymer impurity A and simplified the process by omitting column chromatography. The optimized process achieved a total yield of 17.0%(based on 7), and a purity of 99.6%. It was verified by kilogram-level amplification and was suitable for industrial production.
Herein two related substances(A and B) of voclosporin(1) were prepared and purified. Compound B was Z-isomer of 1, named cyclo-[[(6Z)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6,8-nonadienoyl]-L-2-aminobutyryl-N-methyl-glycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl]. E configuration of acetylated voclosporin(5) was transferred into related substance B via configuration conversion and acetyl group removal under triethylamine/lithium bromide with high-purity, which was reported at the first time. In addition, in the process optimization of 1, the over-oxidized impurity, related substance A was found and prepared for the first time. Its structure was confirmed as acetylated cyclosporine A acid by high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy. The above two compounds can be served as the references for the quality control of 1.
Oral urate oxidase promotes intestinal uric acid excretion for gout treatment. To enhance the adhesion and uric acid degradation efficiency of recombinant pig-baboon chimeric urate oxidase(PBC) in the intestine, this study fused the mucin-binding protein(MUB) fragments with PBC to construct fusion proteins N1 to N7. By comparing the effects of different MUB fragments on the mucin-binding activity of PBC, and further investigating the high-density fermentation, separation, purification, and enzymatic properties of N5, it was found that the mucin-binding activity of fusion proteins N1 to N7 was significantly improved. Among them, the fusion protein N5, which linked the MUB fragment RⅣ at the N-terminus, showed a nearly 41-fold increase in mucin-binding activity. Using high-density fermentation, ammonium sulfate precipitation, polyethyleneimine clarification, and anion exchange chromatography, the purity of N5 reached 98.7%,with a fermentation yield of 4.47 g/L. Additionally, the specific activity of N5(0.52 IU/mg) increased by 30% compared to PBC, with enhanced substrate affinity(Km=14.29 μmol/L), and it remained stable under room temperature, alkaline conditions, and in the presence of common metal ions. This study provides a reference for the subsequent development of oral urate oxidase as a candidate drug.